Experiences with
Ustekinumab17 public posts
Want to take advantage of all our features? Just log in!
or
Sweet Syndrome Associated With Crohn’s Disease Developed After a Combo Therapy With Infliximab and Azathioprine
Ustekinumab binds to both IL-12 and IL-23 which prevents them from working, helping to relieve inflammation and symptoms. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791332/